Tag: Deepak Jotwani
Indian pharma companies to grow by 6-7% in FY2023: ICRA study
Headwinds related to pricing pressures in the US generics market and rising raw material costs will result in contraction of sample set profit margins in FY2023
Outlook 2022: Pharma experts predict a stable future for the industry
The last two years steered the pharma industry towards innovative breakthroughs across the patient journey that helped the world recover from the pandemic






















































